We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Artificial Intelligence Helps Detect Rare Diseases

By HospiMedica International staff writers
Posted on 18 Jun 2019
Print article
A child with Kabuki Syndrome (Photo courtesy of Wikimedia).
A child with Kabuki Syndrome (Photo courtesy of Wikimedia).
A new study suggests that an artificial intelligence (AI) neural network can be used to automatically combine portrait photos and genetic data to diagnose rare diseases more efficiently.

The prioritization of exome data by image analysis (PEDIA) project, under development by the University of Bonn (Germany), GeneTalk (Bonn, Germany), Charité University Medicine (Charité; Berlin, Germany), and other institutions, is designed to interpret exome data by analyzing sequence variants in portrait photographs, and integrating the results using the DeepGestalt phenotyping tool, a product of FDNA (Herzliya, Israel), which was trained with around 30,000 portrait pictures of people affected by rare syndromal diseases.

In a proof of concept study, the researchers measured the value added by computer-assisted image analysis to the diagnostic yield on a cohort consisting of 679 individuals with 105 different monogenic disorders. For each separate case, frontal photos, clinical features, and the disease-causing variants were submitted. The results showed that computer-assisted analysis of frontal photos improved the top 1% accuracy rate by more than 20–89%, and the top 10% accuracy rate by more than 5–99% for the disease-causing gene. The study was published on June 5, 2019, in Nature Genetics in Medicine.

“In combination with facial analysis, it is possible to filter out the decisive genetic factors and prioritize genes. Merging data in the neuronal network reduces data analysis time and leads to a higher rate of diagnosis,” said senior author Professor Peter Krawitz, MD, PhD, director of the Institute for Genomic Statistics and Bioinformatics at the University of Bonn. “This is of great scientific interest to us and also enables us to find a cause in some unsolved cases.”

“PEDIA is a unique example of next-generation phenotyping technologies,” said Dekel Gelbman, CEO of FDNA. “Integrating an advanced AI and facial analysis framework such as DeepGestalt into the variant analysis workflow will result in a new paradigm for superior genetic testing.”

Many rare diseases cause characteristic abnormal facial features in those affected, such as Kabuki syndrome, which is reminiscent of the make-up of a traditional Japanese form of theatre. The eyebrows are arched, the eye-distance is wide and the spaces between the eyelids are long. Another example is mucopolysaccharidosis, which leads to bone deformation, stunted growth, and learning difficulties. Such phenotype information has so far only been accessible for bioinformatics workflows after encoding into clinical terms by expert dysmorphologists.


Related Links:
University of Bonn
GeneTalk
Charité University Medicine
FDNA


Gold Member
12-Channel ECG
CM1200B
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
X-Ray QA Meter
Piranha CT

Print article

Channels

Critical Care

view channel
Image: The stretchable microneedle electrode arrays (Photo courtesy of Zhao Research Group)

Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment

The field of personalized medicine is transforming rapidly, with advancements like wearable devices and home testing kits making it increasingly easy to monitor a wide range of health metrics, from heart... Read more

Surgical Techniques

view channel
Image: NICO SPECTRA is only hand-held technology delivering blue light closer to target to enhance tissue fluorescence (Photo courtesy of NICO Corporation)

Handheld Device for Fluorescence-Guided Surgery a Game Changer for Removal of High-Grade Glioma Brain Tumors

Grade III or IV gliomas are among the most common and deadly brain tumors, with around 20,000 cases annually in the U.S. and 1.2 million globally. These tumors are very aggressive and tend to infiltrate... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more